UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

Journal of clinical oncology, 2015-09, Vol.33 (27), p.2999-3007

2015

Volltextzugriff (PDF)

Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia

PLoS genetics, 2016-01, Vol.12 (1), p.e1005783-e1005783

2016

Volltextzugriff (PDF)

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

Cancer, 2018-08, Vol.124 (16), p.3381-3389

2018

Volltextzugriff (PDF)

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1558-1568

2020

Volltextzugriff (PDF)

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532

Journal of clinical oncology, 2018-01, Vol.36 (3), p.254-261

2018

Volltextzugriff (PDF)

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2769-2777

2019

Volltextzugriff (PDF)

Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2

American journal of roentgenology (1976), 2020-05, Vol.214 (5), p.987-994

2020

Volltextzugriff (PDF)

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Pediatric blood & cancer, 2013-06, Vol.60 (6), p.994-1000

2013

Volltextzugriff (PDF)

Impact of the First Generation of Children’s Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor

Journal of the National Comprehensive Cancer Network, 2021-08, Vol.19 (8), p.978-985

2021

Volltextzugriff (PDF)

Disclosing Secondary Findings from Pediatric Sequencing to Families: Considering the "Benefit to Families"

The Journal of law, medicine & ethics, 2015-09, Vol.43 (3), p.552-558

2015

Volltextzugriff (PDF)

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Cancer, 2020-12, Vol.126 (23), p.5156-5164

2020

Volltextzugriff (PDF)

Hospitalized children continue to report undertreated and preventable pain

Pain research & management, 2014, Vol.19 (4), p.198-204

2014

Volltextzugriff (PDF)

Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia

Nature genetics, 2009-06, Vol.41 (6), p.651-653

2009

Volltextzugriff (PDF)

Germline mutations in MAP3K6 are associated with familial gastric cancer

PLoS genetics, 2014-10, Vol.10 (10), p.e1004669-e1004669

2014

Volltextzugriff (PDF)

Understanding the translation of scientific knowledge about arsenic risk exposure among private well water users in Nova Scotia

The Science of the total environment, 2015-02, Vol.505, p.1259-1273

2015

Volltextzugriff (PDF)

Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting

Genetics in medicine, 2013-07, Vol.15 (7), p.558-564

2013

Volltextzugriff (PDF)

The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes

Haematologica (Roma), 2015-05, Vol.100 (5), p.633-642

2015

Volltextzugriff (PDF)

Study of Glycine and Folic Acid Supplementation to Ameliorate Transfusion Dependence in Congenital SLC25A38 Mutated Sideroblastic Anemia

Pediatric blood & cancer, 2016-07, Vol.63 (7), p.1307-1309

2016

Volltextzugriff (PDF)

Ethical Issues for Control-Arm Patients After Revelation of Benefits of Experimental Therapy: A Framework Modeled in Neuroblastoma

Journal of clinical oncology, 2013-02, Vol.31 (5), p.641-646

2013

Volltextzugriff (PDF)

Providing research results to study participants: support versus practice of researchers presenting at the American Society of Hematology annual meeting

Blood, 2005-08, Vol.106 (4), p.1199-1202

2005

Volltextzugriff (PDF)

Recommendations for the Return of Research Results to Study Participants and Guardians: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-12, Vol.30 (36), p.4573-4579

2012

Volltextzugriff (PDF)

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533

Journal of clinical oncology, 2022-09, Vol.40 (26), p.3047-3056

2022

Volltextzugriff (PDF)

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

Journal of clinical oncology, 2016-09, Vol.34 (26), p.3189-3194

2016

Volltextzugriff (PDF)

Parental views on tissue banking in pediatric oncology patients

Pediatric blood & cancer, 2011-12, Vol.57 (7), p.1217-1221

2011

Volltextzugriff (PDF)

Essential medicines for childhood cancer in Europe

The lancet oncology, 2023-02, Vol.24 (2), p.e67-e67

2023

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(188)

Sprache

Englisch
(231)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study

Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report

Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Impact of the First Generation of Children’s Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor

Disclosing Secondary Findings from Pediatric Sequencing to Families: Considering the "Benefit to Families"

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Hospitalized children continue to report undertreated and preventable pain

Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia

Germline mutations in MAP3K6 are associated with familial gastric cancer

Understanding the translation of scientific knowledge about arsenic risk exposure among private well water users in Nova Scotia

Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting

The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes

Study of Glycine and Folic Acid Supplementation to Ameliorate Transfusion Dependence in Congenital SLC25A38 Mutated Sideroblastic Anemia

Ethical Issues for Control-Arm Patients After Revelation of Benefits of Experimental Therapy: A Framework Modeled in Neuroblastoma

Providing research results to study participants: support versus practice of researchers presenting at the American Society of Hematology annual meeting

Recommendations for the Return of Research Results to Study Participants and Guardians: A Report From the Children's Oncology Group

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group

Parental views on tissue banking in pediatric oncology patients

Essential medicines for childhood cancer in Europe

Aktive Filter

Suchergebnisse filtern